Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank71
3Y CAGR+3.8%
5Y CAGR+17.5%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+3.8%/yr
Annual compound
5Y CAGR
+17.5%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.18 | -31.6% |
| 2024 | 1.72 | -34.6% |
| 2023 | 2.63 | +149.8% |
| 2022 | 1.05 | +54.3% |
| 2021 | 0.68 | +29.9% |
| 2020 | 0.52 | +7101.1% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.00 | -66.2% |
| 2016 | 0.01 | - |